Portland, OR -- (SBWire) -- 03/02/2018 --Many Americans deal with fertility issues at some point in their lives, and more than 11% of women seek fertility services. But according to a new report, published by Allied market Research whether or not a woman has access to the clinics that provide these services depends on where she lives. In the United States, about 40% of women of reproductive age—25 million women in total—have limited or no access to assisted reproductive technology (ART) clinics, according to a new study published in the journal Fertility & Sterility.
U.S. IVF Services Market was valued at $2,213.1 million in 2015 and is projected to reach $4,472.2 million by 2022, registering a CAGR of 10.6% from 2016 to 2022.
People who want to undergo fertility treatments already face other barriers, including cost. Insurance or employer coverage of fertility treatments is uncommon, and the average cost of an IVF cycle in the U.S. is about $12,400. Even just an appointment with a fertility specialist can cost from $200-400. The study authors argue that substantial travel for fertility treatments adds an additional barrier and expense for women without access to nearby clinics.
Get the sample PDF brochure of U.S IVF Services Industry Insights at: https://tinyurl.com/y8txn6f6
Developments of fertility clinics and novel IVF technologies by key players are expected to offer lucrative growth opportunities for IVF service providers in future. According to Centers for Disease Control and Prevention, the rate of fertilization in the age group of 35-39 years through IVF procedure is considerably high.
Increase in incidence of gynecological conditions coupled with the delayed pregnancy in women fuel the market. Moreover, the increase in number of technological advancements of IVF procedures along with the focus and investments by major players is expected to provide several opportunities for market growth in the future.
The overall number of embryo transfers performed in U.S. stood at 180.4 thousand in 2015 and is expected to reach 353.7 thousand by 2022, registering a CAGR of 10.1% during the forecast period.
Based on cycle type, in 2015, fresh IVF cycle (non-donor) segment accounted for around half share of the total market, in terms of revenue and volume.
Based on end user, clinical research institutes segment is projected to be one of the fastest growing segment at a CAGR of 11.1% in terms of revenue.
Based on end user, in 2015, fertility clinics segment accounted for around three-fifths share of the total market in terms of volume.
Do purchase Inquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/3491
The list of key players profiled in this report include Fertility and Gynecology Center Monterey Bay IVF, Conceptions Reproductive Associates, Servy Massey Fertility Institute, Sher Institute for Reproductive Medicine (SIRM), Cardone Reproductive Medicine & Infertility, Fertility Center of San Antonio, Houston Fertility Center, New hope fertility center, and Reproductive Medicine Associates of New Jersey.
